| 24 May 2026 |
BMK ethyl glycidate CAS 41232-97-7 |
5.3 |
5g |
5.0g |
-1.0% |
98.00% |
Lab A |
| 24 May 2026 |
Dapoxetine |
9.6 |
100mg |
101.9mg |
+1.9% |
96.95% |
Lab C |
| 24 May 2026 |
N-Acetyl Epitalon Amidate |
4.9 |
2mg |
1.8mg |
-10.5% |
96.31% |
Lab F |
| 23 May 2026 |
KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg |
7.3 |
30mg |
33.7mg |
+12.5% |
95.52% |
Lab C |
| 23 May 2026 |
Salbutamol |
7.0 |
25mg |
23.1mg |
-7.4% |
96.33% |
Lab D |
| 23 May 2026 |
1-Boc-4-AP (tert-butyl 4-(phenylamino)piperidine-1-carboxylate) CAS 125541-22-2 |
6.6 |
5g |
5.5g |
+10.2% |
99.91% |
Lab A |
| 23 May 2026 |
Thymalin |
6.2 |
50mg |
49.5mg |
-1.1% |
97.09% |
Lab A |
| 21 May 2026 |
Tirzepatide |
3.7 |
10mg |
11.2mg |
+12.0% |
98.68% |
No Label / Silver Crimp / White Cap |
| 21 May 2026 |
Nitroethane CAS 79-24-3 |
7.7 |
1g |
1.1g |
+8.5% |
96.58% |
Lab G |
| 19 May 2026 |
Isotretinoin |
5.2 |
25mg |
24.6mg |
-1.7% |
98.29% |
Lab E |
| 19 May 2026 |
MT-1 |
4.0 |
20mg |
21.6mg |
+8.0% |
98.68% |
Lab B |
| 17 May 2026 |
CJC-1295 w/o DAC 5mg + IPA 5mg Blend |
7.2 |
20mg |
19.5mg |
-2.5% |
95.45% |
Lab E |
| 17 May 2026 |
GHRP-2 Acetate |
4.3 |
2mg |
1.8mg |
-9.2% |
98.45% |
Lab G |
| 17 May 2026 |
Vilon |
6.5 |
5mg |
5.7mg |
+14.3% |
95.68% |
Lab C |
| 26 Jan 2026 |
Tirzepatide |
5.0 |
30mg |
35.4mg |
+18.0% |
99.80% |
No Label / Copper Crimp / Clear Cap |
| 26 Jan 2026 |
CJC-1295 With DAC |
5.7 |
20mg |
24.6mg |
+23.0% |
96.84% |
Lab C |
| 26 Jan 2026 |
Selank 10mg + Semax 10mg Blend |
8.9 |
5mg |
5.5mg |
+10.6% |
98.70% |
Lab B |
| 9 Jan 2026 |
Cortagen |
4.2 |
2mg |
2.3mg |
+13.9% |
97.78% |
Lab G |
| 7 Jan 2026 |
T3 (Liothyronine) |
4.0 |
25mg |
22.6mg |
-9.4% |
95.67% |
Lab G |
| 6 Jan 2026 |
Livagen |
6.8 |
20mg |
20.3mg |
+1.6% |
99.05% |
Lab G |
| 6 Jan 2026 |
Tadalafil (Cialis) |
4.0 |
20mg |
22.0mg |
+10.0% |
95.71% |
Lab B |
| 6 Jan 2026 |
Vitamin B12 1mg/ml |
9.9 |
300mg/ml |
364.7mg/ml |
+21.6% |
97.85% |
Lab F |
| 1 Jan 2026 |
Retatrutide |
6.3 |
10mg |
10.9mg |
+9.0% |
99.70% |
(no data) |
| 29 Dec 2025 |
Retatrutide |
9.7 |
10mg |
10.6mg |
+6.0% |
99.91% |
White Label / Silver Crimp / Clear Blue Cap |
| 29 Dec 2025 |
EPO |
4.9 |
30mg |
25.7mg |
-14.2% |
98.03% |
Lab F |
| 29 Dec 2025 |
TrenMix 200 |
7.9 |
100mg/ml |
114.3mg/ml |
+14.3% |
95.36% |
Lab E |
| 13 Dec 2025 |
Tirzepatide |
4.7 |
60mg |
67.8mg |
+13.0% |
99.40% |
No Label / Copper Crimp / Clear Cap |
| 13 Dec 2025 |
Retatrutide |
6.8 |
20mg |
21.4mg |
+7.0% |
99.70% |
No Label / Copper Crimp / Clear Cap |
| 5 Dec 2025 |
BAM15 |
10.0 |
100mg |
120.2mg |
+20.2% |
95.98% |
Lab A |
| 5 Dec 2025 |
Immunological Enhancement (Glutathione 200mg+Ascorbic Acid 200mg+Zinc Sulfate 2.5mg) |
5.0 |
250mg/ml |
225.6mg/ml |
-9.7% |
99.82% |
Lab F |
| 23 Nov 2025 |
Tirzepatide Oral |
6.0 |
100mg |
118.5mg |
+18.5% |
96.81% |
Lab D |
| 17 Nov 2025 |
Cagrilintide 5mg + Semaglutide 5mg Blend |
4.0 |
10mg |
12.2mg |
+21.5% |
98.18% |
Lab C |
| 17 Nov 2025 |
Tren Base |
5.7 |
200mg/ml |
179.6mg/ml |
-10.2% |
95.19% |
Lab A |
| 5 Nov 2025 |
Cardiogen |
4.9 |
5mg |
5.2mg |
+4.3% |
96.96% |
Lab C |
| 5 Nov 2025 |
IGF-1 LR3 |
5.4 |
30mg |
27.8mg |
-7.4% |
96.39% |
Lab G |
| 17 Oct 2025 |
Orforglipron |
8.7 |
25mg |
29.5mg |
+18.1% |
97.00% |
Lab F |
| 17 Oct 2025 |
Testosterone Decanoate Raw |
9.1 |
1g |
1.2g |
+15.0% |
95.22% |
Lab G |
| 9 Oct 2025 |
Arimidex (Anastrozole) |
10.0 |
20mg |
21.9mg |
+9.3% |
97.98% |
Lab C |
| 9 Oct 2025 |
Glutathione |
5.7 |
30mg |
30.7mg |
+2.5% |
99.91% |
Lab B |
| 9 Oct 2025 |
Ostarine (MK-2866) |
7.6 |
100mg |
104.1mg |
+4.1% |
98.38% |
Lab F |
| 9 Oct 2025 |
Tamoxifen (Nolvadex) Raw |
5.3 |
100g |
102.2g |
+2.2% |
95.43% |
Lab G |
| 9 Oct 2025 |
Test Enanthate |
6.7 |
100mg/ml |
121.8mg/ml |
+21.8% |
95.22% |
Lab D |
| 3 Oct 2025 |
Retatrutide 30mg Pen Kit |
8.3 |
50mg |
57.1mg |
+14.3% |
95.83% |
Lab A |
| 6 Dec 2025⚠️ |
Tirzepatide |
8.0 |
30mg |
31.1mg |
+3.7% |
99.95% |
No Label / Silver Crimp / Clear Teal Cap |